Histology of an undisplaced femoral fatigue fracture in association with bisphosphonate treatment. Frozen bone with remodelling at the crack.
Department of Orthopaedics, IKE, Faculty of Health Sciences, Linköping University, Sweden. per.aspenberg@liu.se
Per
P
Aspenberg
Jörg
J
Schilcher
Anna
A
Fahlgren
D019386:Alendronate / Q000008:administration & dosage / Q000009:adverse effects; D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001858:Bone Nails; D001862:Bone Resorption / Q000139:chemically induced / Q000473:pathology; D012968:Etidronic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D005260:Female; D005264:Femoral Fractures / Q000139:chemically induced / Q000000981:diagnostic imaging / Q000473:pathology* / Q000601:surgery; D005594:Fracture Fixation, Intramedullary / Q000379:methods; D015775:Fractures, Stress / Q000139:chemically induced / Q000000981:diagnostic imaging / Q000473:pathology* / Q000601:surgery; D006801:Humans; D008875:Middle Aged; D011859:Radiography; D000068296:Risedronic Acid
D050071:Bone Density Conservation Agents; D000068296:Risedronic Acid; D012968:Etidronic Acid; D019386:Alendronate